EcoDrugPlus

Purinergic Receptor P2y2

Ensembl ID : ENSDNOG00000045004
Gene Symbol: P2RY2
4 Cross references
200 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSDNOG00000015519
Gene Symbol: P2RY4
4 Cross references
168 Possible Orthologues:

Pyrimidinergic Receptor P2y6

Ensembl ID : ENSDNOG00000018881
Gene Symbol: P2RY6
2 Cross references
183 Possible Orthologues:

Renin

Ensembl ID : ENSDNOG00000033799
Gene Symbol: REN
2 Cross references
220 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSDNOG00000019676
Gene Symbol: RET
4 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSDNOG00000046532
Gene Symbol: RARA
2 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSDNOG00000010433
Gene Symbol: RARB
2 Cross references
451 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSDNOG00000044228
Gene Symbol: RXRA
2 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSDNOG00000015431
Gene Symbol: RXRB
4 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSDNOG00000037217
Gene Symbol: RXRG
4 Cross references
277 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSDNOG00000046031
Gene Symbol: RPL10A
4 Cross references
302 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSDNOG00000011230
Gene Symbol: RPL11
2 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).